🔺5 Emerging HealthTech Startups to Watch in Asia 2025

List of 5 Emerging HealthTech Startups to Watch in Asia 2025

Here’s the list of companies recognized under the ‘5 Emerging HealthTech Startups to Watch in Asia 2025’ issue.

List of 5 Emerging HealthTech Startups to Watch in Asia 2025

list-of-5-emerging-healthtech-startups-to-watch-in-asia-2025

Company Management Description
Boston Medical Sciences

b-ms.tech

Daisuke Tsuge, Director & COO
Boston Medical Sciences, or BMS, is a cross-border healthtech company specializing in advanced medical imaging and diagnostics. With operational bases in both Japan and the United States, the company is driven by a mission to create clinically grounded, practically useful tools for healthcare professionals. 
Halodoc

halodoc.com

Jonathan Sudharta, Co-Founder & CEO 
Halodoc is a leading Indonesian healthcare technology company that has transformed how healthcare services are accessed in the country. Founded with the mission to make healthcare more accessible and convenient, the company connects users with licensed doctors for consultations via video calls, chat, and voice. 
Moom Health

moom.health

Mili Kale and Maya Kale, Co-Founders
Moom Health is a Singapore-based healthtech brand offering personalized supplements designed to address women’s health issues such as hormonal imbalance, sleep disturbances, stress, and menstrual discomfort. 
Intellect

intellect.co

Theodoric Chew Co-Founder & CEO Intellect is a mental health platform focused on providing accessible, affordable, and personalized support. It offers digital tools and professional services to help individuals manage their well-being, addressing both everyday challenges and deeper mental health concerns.
Thuocsi

thuocsi.vn/home

Peter Nguyen, Co-Founder and CEO The healthcare sector in Vietnam has experienced significant growth and transformation, with digital innovation playing a key role in shaping its future. Thuocsi, a startup founded in 2020, is at the forefront of this change, offering a solution to a fragmented pharmaceutical market.